OXYGENE
Novasep Process
Trademark Registered: 2021-11-02
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79280749 |
| Registration Number | 6541534 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2020-01-15 | Application Filed |
| 2020-03-12 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-03-12 | Status: Live/Pending |
| 2020-03-13 | Transaction Date |
| 2021-11-02 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  NOVASEP PROCESS |
| Entity Statement | Société par Actions Simplifiée |
| Address | Boulevard de la Moselle - Site Eiffel F-54340 POMPEY FR |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0401 | Supply of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field |
| GS0401 | Supply in the nature of custom manufacture of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-03-12 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-13 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2020-03-17 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-04-01 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-04-10 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-04-11 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-04-28 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-04-28 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2020-05-15 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-07-14 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-07-14 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-07-14 | 12 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2020-07-20 | 13 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2020-07-20 | 14 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-07-20 | 15 GNFN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-10-26 | 16 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-10-26 | 17 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-10-26 | 18 TCCA I:Incoming Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2021-01-19 | 19 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2021-01-19 | 20 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2021-01-19 | 21 EXPI T:TTAB Proceeding |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2021-01-19 | 22 ERFR I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2021-01-26 | 23 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2021-01-26 | 24 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-01-26 | 25 GNS3 O:Outgoing Correspondence |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-03-05 | 26 NREP P: |
| CORRECTION TRANSACTION RECEIVED FROM IB | 2021-04-03 | 27 CRCV M: |
| CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2021-04-06 | 28 CORN I:Incoming Correspondence |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-04-09 | 29 NREP P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2021-05-10 | 30 CHLD M: |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2021-05-25 | 31 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-07-09 | 32 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-07-13 | 33 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-07-13 | 34 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-07-14 | 35 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-07-28 | 36 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2021-07-28 | 37 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2021-07-28 | 38 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2021-08-14 | 39 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2021-08-17 | 40 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-08-17 | 41 NPUB E:E-Mail |
| ASSIGNED TO EXAMINER | 2021-08-23 | 42 DOCK D:Assigned to Examiner |
| REGISTERED-PRINCIPAL REGISTER | 2021-11-02 | 43 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-02-02 | 44 FICR P: |
| FINAL DISPOSITION PROCESSED | 2022-04-21 | 45 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2022-04-21 | 46 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-05-15 | 47 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2024-05-04 | 48 NREP P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 